低氧激活和光放大的帕克利塔塞尔释放,用于增强光动力学和化疗
Jianxin Rong1, Furou Lv1, Ruoxue Wang1
1Institute of Polymer Science and Engineering, School of Chemical Engineering, Hebei University of Technology, Tianjin 300130, China.
Biomacromolecules
|August 1, 2025
概括
工程纳米颗粒结合了 (III) 复合物和帕克利塔塞尔前药物用于癌症治疗. 光激活触发了活性氧物种的产生和药物释放,提高了化疗的疗效,并最大限度地减少了副作用.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- (III) 复合物提供可调节的发射和光激活,用于光动力学疗法 (PDT).
- 帕克利塔塞尔 (PTX) 是一种强效的化疗药物,稳定性差,效果偏离目标.
- 缺氧是固体瘤的常见特征,影响治疗反应.
研究的目的:
- 为精确的癌症治疗设计集成光动力疗法和化疗的自我放大纳米粒子.
- 开发一种对缺氧反应的药物输送系统,以增强帕克利塔塞尔释放.
- 研究光激活PDT和PDT加速化疗的协同效应.
主要方法:
- 聚碳酸-- (III) 结合物 (PC-Ir) 和对低氧反应的帕克利塔塞尔前药物 (PTX2-Azo) 的合成.
- 自放大纳米颗粒的制造,结合PC-Ir和PTX2-Azo.
- 在660nm激光照射下评估反应性氧物种 (ROS) 的产生.
- 评估因低氧和二氧化碳生成引发的PTX释放.
- 在体外和体内研究,以评估治疗疗效和安全性.
主要成果:
- 在激光照射后,PC-Ir纳米粒子通过I型和II型通路高效地产生ROS.
- PDT诱导的低氧促进了PTX从PTX2-Azo释放,而CO2生成促进了纳米粒子逃逸.
- 前药物策略抑制了药物过早泄漏,改善了PTX的稳定性.
- 联合PDT和化疗显示出协同作用的抗癌效应,并最大限度地降低了目标外毒性.
结论:
- 工程自放大纳米粒子为综合光动力学疗法和化疗提供了一个有前途的平台.
- 低氧反应的前药物系统可以提高药物输送和治疗结果.
- 这种方法为精确的癌症治疗提供了一种策略,提高了疗效和减少了副作用.
更多相关视频
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.2K
相关概念视频
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
